Bortezomib-Based Induction Therapy Followed by Autologous Stem Cell Transplantation and Maintenance Therapy with Bortezomib Improves Outcome In Myeloma Patients with Gain 1q21 and t(4;14) - a Subgroup Analysis of the HOVON-65/GMMG-HD4 Trial

Autor: Goldschmidt, Hartmut, Neben, Kai *, Bertsch, Uta *, Hielscher, Thomas *, van der Holt, Bronno *, Hose, Dirk *, Jarari, Laila el *, Salwender, Hans *, Blau, Igor Wolfgang *, Pfreundschuh, Michael, Duehrsen, Ulrich, Weisel, Katja *, Martin, Hans *, Lindemann, Walter *, Teschendorf, Christian *, Haenel, Mathias *, Scheid, Christof *, van de Velde, Helgi *, Derigs, Hans Guenter *, Hoffmann, Martin *, Peter, Norma *, Kaufmann, Martin *, Schmidt-Wolf, Ingo *, Jauch, Anna *, Lokhorst, Henk M *, Sonneveld, Pieter
Zdroj: In Blood 19 November 2010 116(21):305-305
Databáze: ScienceDirect